C. Harris FloudasNov 24, 2022

RT @pashtoonkasi: 🆕 Just published @NatureMedicine @Nature

Editorial on✍🏽
#LiquidBiopsies & the Tumor Mutational Burden cutoff conundrum.

🩸Blood-TMB or plasma-TMB cutoffs need to be harmonized; across platforms, & tissue🆚 liquid.

💡Thoughts?

#ESMO22
https://t.co/kCNQXsWvmy https://t.co/7PSeRahcjK

@oncology

Liquid biopsies and tumor mutational burden: the cutoff conundrum - Nature Medicine

Assessment of tumor mutational burden through a simple blood test could help to identify which patients are most likely to benefit from immunotherapy, but optimal cutoffs are not well established.

Nature